Menu
Search
|

Menu

Close
X

Apollo Endosurgery Inc APEN.OQ (NASDAQ Stock Exchange Global Market)

8.28 USD
+0.18 (+2.22%)
As of 1:30 AM IST
chart
Previous Close 8.10
Open 8.06
Volume 11,846
3m Avg Volume 13,908
Today’s High 8.45
Today’s Low 8.00
52 Week High 9.56
52 Week Low 3.60
Shares Outstanding (mil) 17.25
Market Capitalization (mil) 94.37
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 4 analysts

KEY STATS

Revenue (mm, USD)
FY18
16
FY17
64
FY16
65
FY15
68
EPS (USD)
FY18
-0.470
FY17
-2.148
FY16
-108.276
FY15
-608.947
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.76
Price to Sales (TTM)
vs sector
1.50
5.73
Price to Book (MRQ)
vs sector
2.08
5.47
Price to Cash Flow (TTM)
vs sector
--
23.29
Total Debt to Equity (MRQ)
vs sector
117.56
16.84
LT Debt to Equity (MRQ)
vs sector
117.56
12.51
Return on Investment (TTM)
vs sector
-120.83
14.61
Return on Equity (TTM)
vs sector
-210.67
16.34

EXECUTIVE LEADERSHIP

Richard Meelia
Chairman of the Board, Since 2012
Salary: --
Bonus: --
Todd Newton
Chief Executive Officer, Director, Since 2014
Salary: $400,000.00
Bonus: --
Stefanie Cavanaugh
Chief Financial Officer, Secretary, Since 2015
Salary: --
Bonus: --
Bret Schwartzhoff
Vice President,North America Sales and Global Marketing, Since 2017
Salary: $267,267.00
Bonus: --
Christopher Gostout
Chief Medical Officer, Since 2017
Salary: $220,000.00
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

1120 South Capital Of Tx Hwy
Building 1 Suite 300
WEST LAKE HILLS   TX   78746-6464

Phone: +1512.2795100

Apollo Endosurgery, Inc., formerly Lpath, Inc., is a medical device company. The Company is focused on less invasive therapies for the treatment of obesity, as well as other gastrointestinal disorders. The Company's device-based therapies are an alternative to invasive surgical procedures. The Company offers products in over 80 countries. The Company's products include ORBERA, LAP-BAND and OverStitch. The Company's product, ORBERA, is a gastric balloon. The ORBERA Intragastric Balloon System is a weight loss aid for adults suffering from obesity. The LAP-BAND System is a minimally invasive procedure that offers weight loss. The LAP-BAND System is indicated for weight reduction for patients with obesity. The OverStitch Endoscopic Suturing System enables advanced endoscopic surgery by allowing physicians to place full-thickness sutures through a flexible endoscope. OverStitch offers solutions for defects in both the upper and lower gastrointestinal tract.

SPONSORED STORIES